Cathay Biotech is one of the representative high-tech enterprises using bio-manufacturing solutions to achieve large-scale production of new materials. It is also an R&D-driven company focused on bio-manufacturing theory, technologies and industrialization methods. Over the years, Cathay has consistently followed an R&D-driven strategy, emphasizing the integration of R&D with market and production needs, and using effective market demand to guide the direction of technology development. Cathay has accumulated extensive R&D achievements in synthetic biology, cell engineering, biochemical engineering, polymer materials and engineering, and has built a multidisciplinary professional R&D team with rich experience in molecular biology, chemistry, polymerization and material applications.

Cathay Biotech has two major R&D platforms: the Shanxi Taiyuan Research Institute and the Shanghai Innovation Center. These platforms focus on the development of new bio-manufacturing technologies and products, with research efforts centered on key technologies such as bio-based raw material supply, AI-assisted R&D, and high-performance thermoplastic continuous fiber composites. They help significantly shorten the industrialization cycle of scientific research achievements and provide renewable bio-based new materials for the industry and partners.

In 2024, the company’s R&D Center was recognized as a National Enterprise Technology Center jointly certified by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs and the State Taxation Administration.